INGEMM, Institute of Medical and Molecular Genetics-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Universidad Autónoma de Madrid, Madrid, Spain.
Mol Genet Genomic Med. 2021 May;9(5):e1649. doi: 10.1002/mgg3.1649. Epub 2021 Mar 18.
Prenatal diagnoses of microdeletion syndromes without ultrasound findings in the first and second trimester are always difficult. The objective of this study is to report the prenatal ultrasound findings in four foetuses diagnosed with 17q21.31 microdeletions (Koolen-de Vries syndrome) using chromosomal microarrays (CMA).
We present four foetuses with 17q21.31 microdeletion. All showed CNS anomalies in the third trimester, three had ventriculomegaly, and one hypogenesis of corpus callosum at 31 weeks of pregnancy.
Array-SNPs and CGH-array were performed on uncultured amniocytes and peripheral blood revealing a 17q21.31 microdeletion.
Prenatal CNS anomalies (mainly ventriculomegaly) at third trimester, in spite of isolate, should be considered a prenatal ultrasound marker of this syndrome. This kind of malformations raise the possibility of an underlying genetic conditions including 17q21.31 microdeletion; thus, CMA should be taken into consideration when offering prenatal genetic counselling.
在第一和第二孕期没有超声发现的微缺失综合征的产前诊断一直存在困难。本研究的目的是报告使用染色体微阵列(CMA)诊断的四例 17q21.31 微缺失(Koolen-de Vries 综合征)胎儿的产前超声发现。
我们介绍了四例 17q21.31 微缺失的胎儿。所有胎儿在妊娠晚期均出现 CNS 异常,三例有脑室扩大,一例在妊娠 31 周时胼胝体发育不良。
对未培养的羊水细胞和外周血进行了 SNP 微阵列和 CGH 微阵列分析,结果显示 17q21.31 微缺失。
尽管孤立存在,但妊娠晚期的产前 CNS 异常(主要是脑室扩大)应被视为该综合征的产前超声标志物。这种畸形增加了存在潜在遗传疾病的可能性,包括 17q21.31 微缺失;因此,在提供产前遗传咨询时应考虑进行 CMA。